Biotechnology Europe is not short of science. It is short of the machinery that turns science into large, durable biotech companies. The continent still has deep academic research, specialist hospitals, public funding, strong disease networks and a patchwork of regional clusters with real depth. From the Nordics to Spain, Belgium, the Netherlands and Italy, Europe can still generate ideas, companies and clinical expertise. 15 May 2026